China’s pet economy is one of the most striking consumer stories of the past decade. From a market that barely registered in global pet industry data in 2010, China has grown into the world’s second-largest pet market by revenue, with industry analysts at Euromonitor estimating total retail sales surpassing $30 billion in 2025 — and trajectory pointing toward $50 billion by 2028. For foreign pet brands, ingredients suppliers, veterinary technology companies, and platform operators, the strategic stakes have never been higher.
What makes China’s pet market uniquely complex is that it didn’t develop the way Western markets did. It compressed roughly 40 years of American pet industry evolution into less than 15 years, skipping straight to premiumization, digital commerce, and humanization trends that only matured in the US and Europe after decades of incremental consumer education. Understanding how that happened is essential for any business operating at the intersection of US-China commerce.
The Numbers Behind the Growth
The China Pet Industry White Paper, published annually by the China Animal Husbandry Association, has documented consistent double-digit growth since 2015. By 2024, an estimated 130 million urban households owned at least one pet, with dogs and cats accounting for approximately 75% of pet ownership. Pet food is the largest segment, representing roughly 50% of total market spend. Royal Canin (Mars), Hills (Colgate-Palmolive), and Purina (Nestlé) entered China early and captured premium positioning, but since 2019 a wave of domestic challengers has rapidly eroded their market share.
Companies such as Yantai China Pet Foods (CPET), Gambol Pet Group, and Navarch have gained significant shelf and platform presence. Gambol, which listed on the Shanghai Stock Exchange in 2021, reported revenue of approximately RMB 1.7 billion ($235 million) in 2024, having grown at a compound annual rate of over 20% since listing. Pet healthcare is the fastest-growing sub-segment. China’s veterinary clinic count has grown from fewer than 8,000 in 2015 to an estimated 28,000 in 2025, according to the China Veterinary Drug Association. Ruipeng Pet Group, backed by Hillhouse Capital and Tencent and operating more than 1,000 clinics nationwide, is now the dominant infrastructure player in veterinary care.
How Digital Commerce Rewired the Industry
Unlike Western markets, where pet specialty retail chains long dominated distribution, China’s pet economy was born digital. Taobao and Tmall (Alibaba) captured early pet product commerce, and JD.com’s emphasis on cold-chain logistics made it the preferred platform for fresh and frozen pet food. The most disruptive recent development has been the rise of live-streaming commerce for pet products. Platforms including Douyin (TikTok’s domestic version) and Kuaishou host hundreds of dedicated pet product merchants doing real-time demonstrations for audiences of tens of thousands. A single top-tier pet product livestreamer on Douyin can move upward of RMB 10 million ($1.4 million) in goods during a single broadcast session.
This has compressed brand-building timelines dramatically. A domestic pet food brand can go from concept to national recognition in 18 months if its livestreaming content performs. As documented in our analysis of China’s FMCG revolution, this pattern of platform-native brand acceleration is now repeating across virtually every fast-moving consumer goods category.
The Humanization Premium: Why Chinese Pet Owners Spend More
Chinese pet industry analysts use the term “pet parenting” (宠物亲子化) to describe a cultural shift that accelerated during the COVID-19 lockdown period of 2020-2022. Urban Chinese millennials and Gen Z consumers, many of whom are single or delaying marriage, have demonstrated a willingness to spend on pets that rivals what their cohort spends on themselves. Average annual spend per pet-owning household in China’s Tier 1 cities (Beijing, Shanghai, Guangzhou, Shenzhen) is now estimated at RMB 7,000-12,000 ($970-$1,660), comparable to midrange European markets.
The nutraceutical segment is particularly relevant for US exporters. American brands such as Zesty Paws and Vetri-Science have established significant followings on Tmall Global, partly because Chinese pet owners perceive US-made supplements as subject to rigorous FDA oversight. This perception premium has created a durable import market that US brands should not take for granted. The Yum China localization blueprint demonstrates that foreign brand premium positioning in Chinese consumer markets requires consistent local investment to be maintained over time.
Regulatory Architecture: What Foreign Businesses Must Know
The regulatory environment for pet products in China has tightened substantially since 2020. The Ministry of Agriculture and Rural Affairs (MARA) mandates that imported pet food producers register their facilities before products can clear Chinese customs. Imported pet food must comply with updated labeling requirements under the Administrative Measures for Pet Feed (宠物饲料管理办法), requiring Chinese-language ingredient lists, net weight, manufacture and expiry dates, and valid importer registration.
The General Administration of Customs (GACC) maintains a Registered Overseas Manufacturer list for animal product imports, including pet food, accessible at www.gacc.gov.cn. US pet food exporters must be on this list. The USDA’s Animal and Plant Health Inspection Service (APHIS) issues the required export health certificates, and the USDA Foreign Agricultural Service maintains China-specific import data and regulatory updates at its China agricultural trade portal. Exporters who bypass the GACC registration system risk full cargo rejection at Chinese ports.
Veterinary Pharmaceuticals: A Separate Track
Veterinary pharmaceuticals face additional scrutiny. Prescription drugs approved by the US FDA’s Center for Veterinary Medicine are not automatically recognized by China’s Veterinary Drug Registration system under MARA. Products must undergo separate Chinese registration, a process that can take 18-36 months for new compounds. This creates a structural advantage for joint venture arrangements with Chinese veterinary pharmaceutical companies, which can expedite registration through their established regulatory relationships.
Domestic Champions and the Export Dimension
Chinese pet food manufacturers have long served as OEM suppliers to Western private-label brands, but a growing number are now building their own export brands. Wuhan-based Navarch has established distribution in Southeast Asia and the Middle East. Gambol launched an international division in 2023, prioritizing markets where pet humanization trends are accelerating along a curve similar to China’s in 2015.
On Amazon US, the pet supplies category now features multiple Chinese brands with thousands of reviews in water fountains, automatic feeders, GPS trackers, and grooming tools, often priced 30-50% below comparable Western brands. This dynamic mirrors patterns already documented in our coverage of how Greenworks, EGO, and WORX conquered Western outdoor power equipment markets and the broader OEM-to-OBM transition reshaping Chinese industry.
Investment Flows and Supplier Partnerships
Between 2020 and 2025, Chinese pet industry companies raised an estimated RMB 15 billion ($2.1 billion) in disclosed venture and private equity funding, with Ruipeng Pet Healthcare, Petpal Technology, and Guiwei Pet among the most notable recipients. For Western companies, the most frequently overlooked partnership opportunity is co-development with Chinese ingredient processors. China is the world’s largest producer of hydrolyzed proteins, functional peptides, and freeze-dried single-protein ingredients at costs substantially below comparable US or European processors.
Due diligence on Chinese ingredient suppliers remains essential. Contamination incidents have shaped Western consumer perception, and the tools for verifying Chinese supplier credentials have improved substantially, from third-party audit platforms such as SGS and Bureau Veritas to the GACC’s own traceability databases. The foundational approach is covered in our guide to conducting proper due diligence on Chinese suppliers.
What the Next Five Years Look Like
Several structural forces will shape China’s pet economy through 2030. The continued decline in China’s birth rate increases the share of households without children, a demographic that correlates globally with higher per-capita pet spending. Tier 2 and Tier 3 city markets including Wuhan, Chengdu, Xi’an, and Zhengzhou are entering the pet humanization phase that Tier 1 cities experienced around 2018-2020 and represent the next major volume expansion.
Regulatory standardization is gradually aligning Chinese pet food standards with AAFCO (Association of American Feed Control Officials) nutritional profiles, reducing barriers for US brands entering China and simultaneously raising the baseline for Chinese brands competing internationally. The integration of AI-driven health monitoring in products from companies such as Petkit and iFly is creating new data infrastructure for veterinary care, creating a compelling arena for joint US-China product development.
China’s pet economy is a $30 billion and growing sector where premiumization, digital commerce dominance, regulatory evolution, and manufacturing competitiveness are playing out at speed. Businesses that engage now as importers, exporters, investors, or technology partners will find a market that rewards preparation and penalizes assumptions borrowed from other industries or other eras.